---
figid: PMC2699120__JEM_20071887_RGB_Fig7
figlink: /pmc/articles/PMC2699120/figure/fig7/
number: Figure 7
caption: Model of the NKG2D signaling pathway in CTLs. The NKG2D cytolytic signaling
  pathway involves PLC-γ2, Vav1, and PI3-K activation (). How these upstream signaling
  events are interconnected in CTLs remains to be determined. NKG2D-mediated cytolysis
  requires activation of cPLA2 and AA release, suggesting that the level of calcium
  mobilization achieved upon NKG2D cross-linking is insufficient to allow membrane
  fusion events and exocytosis. Cytosolic PLA2 activation itself is mediated through
  two independent pathways, Vav-1→JNKK1/2→JNK1/2→cPLA2 and PI3-K→MEK1/2→ERK→cPLA2.
  It is likely that these pathways also promote granule polarization (, , ). In addition,
  cPLA2 activation is also required for NKG2D cytolytic co-stimulatory functions.
  Interestingly, IL-15, which licenses NKG2D killing in CTLs (), enhances NKG2D-mediated
  JNK, ERK and cPLA2 phosphorylation, and AA release. Once released, AA can potentially
  be reincorporated into phospholipids, mediate the biosynthesis of eicosanoids and
  induce granulocyte activation.
pmcid: PMC2699120
papertitle: Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac
  disease via NKG2D and IL-15.
reftext: Fangming Tang, et al. J Exp Med. 2009 Mar 16;206(3):707-719.
pmc_ranked_result_index: '32625'
pathway_score: 0.8196968
filename: JEM_20071887_RGB_Fig7.jpg
figtitle: The NKG2D signaling pathway in CTLs
year: '2009'
organisms: Homo sapiens
ndex: 1fa01ee6-df26-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2699120__JEM_20071887_RGB_Fig7.html
  '@type': Dataset
  description: Model of the NKG2D signaling pathway in CTLs. The NKG2D cytolytic signaling
    pathway involves PLC-γ2, Vav1, and PI3-K activation (). How these upstream signaling
    events are interconnected in CTLs remains to be determined. NKG2D-mediated cytolysis
    requires activation of cPLA2 and AA release, suggesting that the level of calcium
    mobilization achieved upon NKG2D cross-linking is insufficient to allow membrane
    fusion events and exocytosis. Cytosolic PLA2 activation itself is mediated through
    two independent pathways, Vav-1→JNKK1/2→JNK1/2→cPLA2 and PI3-K→MEK1/2→ERK→cPLA2.
    It is likely that these pathways also promote granule polarization (, , ). In
    addition, cPLA2 activation is also required for NKG2D cytolytic co-stimulatory
    functions. Interestingly, IL-15, which licenses NKG2D killing in CTLs (), enhances
    NKG2D-mediated JNK, ERK and cPLA2 phosphorylation, and AA release. Once released,
    AA can potentially be reincorporated into phospholipids, mediate the biosynthesis
    of eicosanoids and induce granulocyte activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VAV3
  - GRB2
  - VAV1
  - PIK3R6
  - PIK3CD
  - PIK3CG
  - RAC3
  - VAV2
  - PIK3R3
  - PIK3CB
  - KAT5
  - KLRK1
  - HCST
  - RAC1
  - PIK3CA
  - MAPK3
  - MAP3K1
  - PLCG1
  - RHOG
  - MAP2K2
  - MAP2K1
  - PIK3R4
  - IL15
  - MAPK1
  - PLCG2
  - RAC2
  - MAPK8
  - PIK3R5
  - MAPK9
  - Leukotrienes
genes:
- word: Vav/Grb2
  symbol: VAV
  source: bioentities_symbol
  hgnc_symbol: VAV3
  entrez: '10451'
- word: Vav/Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Vav/Grb2
  symbol: VAV
  source: bioentities_symbol
  hgnc_symbol: VAV1
  entrez: '7409'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: Vav/Grb2
  symbol: VAV
  source: bioentities_symbol
  hgnc_symbol: VAV2
  entrez: '7410'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CPLA2
  symbol: cPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: KAT5
  entrez: '10524'
- word: NKG2D
  symbol: NKG2-D
  source: hgnc_alias_symbol
  hgnc_symbol: KLRK1
  entrez: '22914'
- word: DAP10
  symbol: DAP10
  source: hgnc_alias_symbol
  hgnc_symbol: HCST
  entrez: '10870'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEKK1
  symbol: MEKK1
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IL-15
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: JNK1/2
  symbol: JNK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: JNK1/2
  symbol: JNK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
chemicals:
- word: Leukotrienes
  source: MESH
  identifier: D015289
diseases: []
---
